CHROMagar™ Candida Plus


Order References

Please use these references when contacting with our:

  • 5000 mL Pack ………..CA242
  • 25 L Pack ………..CA243-25
  • 10 kg Pack ………..CA243-10kg

In Stock

Information Acinetobacter

Colonies Appearance

Colonies Appearance
C. auris (Front)

C. auris (Front)

Light blue with blue halo

C. auris (Back)

C. auris (Back)

Light blue with blue halo

C. albicans

C. albicans

Green-blue

C. tropicalis

C. tropicalis

Metallic blue with pink halo

C. krusei

C. krusei

Pink and fuzzy

C. glabrata

C. glabrata

Mauve

Performance

Performance

Candida are yeast species involved in various infections called candidiasis, which can affect damaged skin, respiratory tract, digestive and urogenital systems. These candidiasis can be severe with significant morbidity for nosocomial infections or in immunocompromised patients. Although C. albicans is still the main species involved, the use of antifungal agents has given rise to other species such as C. tropicalis, C. krusei and C. glabrata.


In 2016, the World Health Organization added C. auris to this list, with a prevalence of over 90 % resistant to fluconazole. In addition, some strains are multidrug resistant to amphotericin B, voriconazole, and/or echinocandins.


CHROMagar™ Candida Plus is the first chromogenic isolation medium to detect and differentiate C. auris in addition to other major clinical Candida species such as C. albicans, C. tropicalis, C. glabrata or C. krusei.

 

Intended Use :

CHROMagar™ Candida Plus is a selective chromogenic culture medium intended for use in the qualitative direct detection, differentiation and presumptive identification of Candida species including C. auris. The test is performed with swabs from skin, throat, ears and vaginal specimens as well as sputum, urine and stools samples, in parallel to cultures on Sabouraud agar, to aid in the Candidiasis diagnosis. Results can be interpreted after 24-48 h of aerobic incubation at 30-37 °C.

Further microbiological testing or epidemiological typing are needed. A lack of growth or the absence of colonies on CHROMagar™ Candida Plus does not preclude the presence of Candida. CHROMagar™ Candida Plus is not intended to diagnose infection nor to guide nor monitor treatment for infections.

1. High Specificity : Differentiation of the most common Candida species with very high specificity (analytical data) :




  • C. albicans  100 %*

  • C. tropicalis  100 %*

  • C. krusei  100 %*


 

* Data obtained after a 48 h incubation at 37 °C in aerobic conditions in the study « Evaluation of a novel chromogenic medium for Candida spp. identification and comparison with CHROMagar™ Candida for the detection of Candida auris in surveillance samples. Mulet Bayona et al., 2020. Diag. Microbiol. Inf. Dis.

2. Unique medium to differentiation C. auris from other Candida species owe to high specificity, it can be used also as a screening tool in case of outbreaks for patient samples and surfaces suspecyted of being contaminated with C. auris.

 

For C. auris :

  • Specificity  100 %*
  • Sensitivity  100 %*

 

** Data obtained after a 24-48 h incubation at 37 °C in aerobic conditions with 364 patients surveillance samples and 212 environmental samples in the study «Novel chromogenic medium CHROMagar™ Candida Plus for detection of Candida auris and other Candida species from surveillance and environmental samples: A multicenter study. Mulet Bayona et al., 2022. J. of Fungi.

3. Easy identification: Identification by MALDI-TOF can be carried directly from a colony. No need of subculture.

Composition

<img class="vce-single-image" src="/Composition-EN-7-1756442697.png" width="670" height="350" alt="" title="Composition EN" />

Technical Documents

PDF CHROMagar™ Candida Plus MSDS
PDF Leaflet
PDF Instructions for Use
Scientific Publications

Scientific Publications

2025

Comparison of Three Chromogenic Agar Plates for the Detection of Candida auris

Brittany Lawson, Warda Memon, and Sean Zhang

📄 Publication

2025

Keep the Hospital Clean: Diagnostic Performance of Ten Different Molecular and Culture‑Based Methods to Detect Candidozyma (Candida) auris

Koos Korsten, Bert Gerrits van den Ende, Rick D. Pique, Ferry Hagen, Karin van Dijk

📄 Publication

2024

Verification, Analytical Sensitivity, Cost-effectiveness, and Comparison of four Candida auris Screening Methods

Adam S Komorowski, Patryk Aftanas, Vanessa Porter, Kevin Katz, Robert A Kozak and Xena X Li

📄 Publication

2024

Candida auris en France en 2023 : épidémiologie nationale, diagnostic, prévention

Jeanne Bigot, Marie Desnos-Ollivier, Pierre Parneix, Anne Berger-Carbonne, Fanny Lanternier, Françoise Botterel, Alexandre Alanio

📄 Publication

2024

Candida auris Identification Using CHROMagar Candida Plus™ and qPCR

Xiao Rui (Lisa) Li, Jonelle Tinsley, David C. Alexander, Tanis C. Dingle, Philippe J. Dufresne, Linda M. Hoang", Julianne V. Kus, Caroline Sheitoyan-Pesant, and Amrita Bharat

📄 Publication

2023

A Novel One Health Approach concerning Yeast Present in the Oral Microbiome of the Endangered Rio Skate (Rioraja agassizii) from Southeastern Brazil

Manoel Marques Evangelista Oliveira, Amanda Pontes Lopes, Tatiane Nobre Pinto, Gisela Lara da Costa, Aristóteles Goes-Neto and Rachel Ann Hauser-Davis

📄 Publication

2023

Evaluation of the CHROMagar Candida Plus mediumfor presumptive identification of yeasts and MALDI-TOF MS identification

Constanza Giselle Taverna, Matías Ezequiel Vivot, Bárbara Abigail Arias and Lucia Irazu Cristina Elena Canteros

📄 Publication

2023

A case of fungal otitis externa caused by coinfection of Candida auris and Aspergillus flavus

Yukitaka Ito, Natsuki Inoue , Naomi Kaneko, Masanobu Otsuka, Shintaro Yamasaki and Mamoru Yoshikawa

📄 Publication

2023

Accuracy of the WASPLab PhenoMATRIX Algorithm for the Identification of Candida auris on Candida Plus CHROMagar Colorex

Miranda, E., Sandino, M. D., and Babady, N.E. Poster ASM Microbe 2023

📄 Publication

2023

Colonized patients by Candida auris: Third and largest outbreak in Brazil and impact of biofilm formation

Camylla Carvalho de Melo, Bruna Rodrigues de Sousa, Gisela Lara da Costa, Manoel Marques Evangelista Oliveira and Reginaldo Gonçalves de Lima-Neto Frontiers in Cellular and Infection Microbiology 23 January 2023

📄 Publication

2023

Utility of CHROMagarTM Candida Plus for presumptive identification of Candida auris from surveillance samples

Anuradha Marathe, YanChun Zhu, Vishnu Chaturvedi, Sudha Chaturvedi

📄 Publication

2023

Isolation of Candida auris in Clinical Specimens

Anamika Yadav, Ashutosh Singh, Anuradha Chowdhary

📄 Publication

2023

A case of fungal otitis externa caused by coinfection of Candida auris and Aspergillus flavus

Yukitaka Ito , Natsuki Inoue, Naomi Kaneko , Masanobu Otsuka, Shintaro Yamasaki and Mamoru Yoshikawa. Journal of Infection and Chemotherapy 31 May 2023

📄 Publication

2022

Evaluation of CHROMagar Candida Plus for presumptive identification of Candida auris

Tamura, T., Alshahni, M.M., and Makimura, K. 2022. Microbiol. Immunol. 66: 292-8.

📄 Publication

2022

Comparison of Candida colonization in intensive care unit patients with and without Covid-19: first prospective cohort study from Turkey

Çaklovica Küçükkaya and al. Poster ISHAM 2022

📄 Publication

2022

Expert recommendations for prevention and management of Candida auris transmission

Aldejohann, A. M., Wiese-Posselt, M., Gastmeier, P., and Kurzai, O. 2022. Mycoses. 65: 590–8.

📄 Publication

2022

Evaluation of a new chromogenic agar for identification of Candida species including Candida auris

Tanis C. Dingle, Bradley Jansen, Wanda Mauricio Alberta Precision Laboratories April 5-8 2022, AMMI Canada, CACMID

📄 Publication

2022

Evaluation and Validation of Optimal Laboratory screening methods using a custom dulcitol agar and commercially available chromogenic agars in detecting Candida auris growth

C. Wong, S. Anwer, A. Airo, A. Corbeil, J. Kus, S.M Poutanen Sinai Health, University of Toronto April 5-8 2022, AMMI Canada, CACMID

📄 Publication

2022

Assesing the limit of detection of Candida auris screening methods using direct-to-agar, broth-enriched-culture, direct-polymerase chain reaction, and broth-enriched-polymerase chain reaction

C. Wong, S. Anwer, S.M. Poutanen Sinai Health, University of Toronto April 5-8 2022, AMMI Canada, CACMID

📄 Publication

2022

Expert Recommendations for prevention and management of Candida auris transmission

Alexander Maximilian Aldejohann, Miriam Wiese-Posselt, Petra Gastmeier, Oliver Kurzai Doi: 10.1111/MYC.13445 2022

📄 Publication

2022

Successful control of Candida auris transmission in a German COVID-19 intensive care unit

C. Hinrichs, M. Wiese-Posselt, B. Graf, C. Geffers, B. Weikert, P. Enghard, A. Aldejohann, A. Schrauder, A. Knaust, K-U. Eckardt, P. Gastmeier, O. Kurzai   Mycoses 2022; 00:1-7

📄 Publication

2022

Novel Chromogenic medium CHROMagar Candida Plus for detection of Candida auris and other Candida species from surveillance and environmental samples: a multi center study

J. V. Mulet Bayona, C. Salvador Garcia, N. Tormo Palop, A. Valentin Martin, C. Gonzalez Padron, J. Colonnina Rodriguez, J. Peman, C. Gimeno Cardona Journal of Fungi 8,181 March 2022

📄 Publication

2021

The performance of two novel chromogenic media for the identification of multi-drug resistant Candida auris compared with other commercially available formulations

Auke W. de Jong, Chendo Dieleman, Mauricio Carbia, Ratna Mohd Tap, Ferry Hagen Journal of Clinical Microbiology February 2021

📄 Publication

2020

Evaluation of a novel chromogenic medium for Candida spp. identification and comparison with CHROMagar Candida for the detection of Candida auris in surveillance samples

Juan V. Mulet Bayona, Carme Salvador Garcia, Nuria Tormo Palop, Concepcion Gimeno Cardona Diagnostic Microbiology & Infectious Disease August 2020

📄 Publication

2020

CHROMagar Candida Plus: A novel chromogenic agar that permits the rapid identification of Candida auris

Andrew M. Borman, Mark Fraser and Elizabeth M. Johnson ISHAM (International Society for Human and Animal Mycology) Medical Mycology, 2020, 0, 1-6

📄 Publication

2020

Candida auris in the UK: Introduction, dissemination, and control

Andrew M. Borman, Elizabeth M. Johnson University of Exeter, United Kingdom PLOS Pathogens July 30, 2020

📄 Publication
All publications

Related Product(s)

main.add_cart_success